New hope for kids with chronic upset stomach: drug trial shows promise
NCT ID NCT04526119
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a medicine called Z-338 in children aged 9 to 17 who have functional dyspepsia, a condition causing stomach pain and fullness after eating. The trial has two parts: first checking how the drug moves through the body, then comparing it to a placebo over 28 days to see if it eases symptoms. All participants then receive the drug for another 28 days. The goal is to find a safe and effective treatment for this common childhood digestive issue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zeria Investigative Site
Matsumoto, Nagano, Japan